Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study

por Menge, Til, Rehberg-Weber, Karin, Taipale, Kirsi, Nastos, Ilias, Jauß, Marek
Publicado 2021

Subcutaneous Interferon Beta Therapy in Multiple Sclerosis Patients – Characterization of Injection Site Reactions and Flu-Like Symptoms in a Daily Practice Setting – Results from...

por Kukowski, Borries, Rehberg-Weber, Karin, Taipale, Kirsi, Kowalik, Andreas, Oschmann, Patrick
Publicado 2021

Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program

por Katsarava, Zaza, Ehlken, Birgit, Limmroth, Volker, Taipale, Kirsi, Patel, Sarita Noemi, Niemczyk, Gabriele, Rehberg-Weber, Karin, Wernsdörfer, Colin
Publicado 2015